556 related articles for article (PubMed ID: 16997888)
21. Contribution of serum response factor and myocardin to transcriptional regulation of smoothelins.
Rensen SS; Niessen PM; Long X; Doevendans PA; Miano JM; van Eys GJ
Cardiovasc Res; 2006 Apr; 70(1):136-45. PubMed ID: 16451796
[TBL] [Abstract][Full Text] [Related]
22. Muscle-specific signaling mechanism that links actin dynamics to serum response factor.
Kuwahara K; Barrientos T; Pipes GC; Li S; Olson EN
Mol Cell Biol; 2005 Apr; 25(8):3173-81. PubMed ID: 15798203
[TBL] [Abstract][Full Text] [Related]
23. Phosphatidylinositol 3-kinase/Akt pathway is involved in transforming growth factor-beta1-induced phenotypic modulation of 10T1/2 cells to smooth muscle cells.
Lien SC; Usami S; Chien S; Chiu JJ
Cell Signal; 2006 Aug; 18(8):1270-8. PubMed ID: 16310342
[TBL] [Abstract][Full Text] [Related]
24. Smooth muscle differentiation marker gene expression is regulated by RhoA-mediated actin polymerization.
Mack CP; Somlyo AV; Hautmann M; Somlyo AP; Owens GK
J Biol Chem; 2001 Jan; 276(1):341-7. PubMed ID: 11035001
[TBL] [Abstract][Full Text] [Related]
25. Myocardin and Prx1 contribute to angiotensin II-induced expression of smooth muscle alpha-actin.
Yoshida T; Hoofnagle MH; Owens GK
Circ Res; 2004 Apr; 94(8):1075-82. PubMed ID: 15016729
[TBL] [Abstract][Full Text] [Related]
26. Reorganization of the actin cytoskeleton via transcriptional regulation of cytoskeletal/focal adhesion genes by myocardin-related transcription factors (MRTFs/MAL/MKLs).
Morita T; Mayanagi T; Sobue K
Exp Cell Res; 2007 Oct; 313(16):3432-45. PubMed ID: 17714703
[TBL] [Abstract][Full Text] [Related]
27. Modulation of pulmonary vascular smooth muscle cell phenotype in hypoxia: role of cGMP-dependent protein kinase and myocardin.
Zhou W; Negash S; Liu J; Raj JU
Am J Physiol Lung Cell Mol Physiol; 2009 May; 296(5):L780-9. PubMed ID: 19251841
[TBL] [Abstract][Full Text] [Related]
28. down-regulation of Kruppel-like factor-4 (KLF4) by microRNA-143/145 is critical for modulation of vascular smooth muscle cell phenotype by transforming growth factor-beta and bone morphogenetic protein 4.
Davis-Dusenbery BN; Chan MC; Reno KE; Weisman AS; Layne MD; Lagna G; Hata A
J Biol Chem; 2011 Aug; 286(32):28097-110. PubMed ID: 21673106
[TBL] [Abstract][Full Text] [Related]
29. Nuclear import mechanism for myocardin family members and their correlation with vascular smooth muscle cell phenotype.
Nakamura S; Hayashi K; Iwasaki K; Fujioka T; Egusa H; Yatani H; Sobue K
J Biol Chem; 2010 Nov; 285(48):37314-23. PubMed ID: 20847050
[TBL] [Abstract][Full Text] [Related]
30. Transforming Growth Factor
Ji Y; Lisabeth EM; Neubig RR
Mol Pharmacol; 2021 Aug; 100(2):53-60. PubMed ID: 34031187
[TBL] [Abstract][Full Text] [Related]
31. Dedicator of cytokinesis 2, a novel regulator for smooth muscle phenotypic modulation and vascular remodeling.
Guo X; Shi N; Cui XB; Wang JN; Fukui Y; Chen SY
Circ Res; 2015 May; 116(10):e71-80. PubMed ID: 25788409
[TBL] [Abstract][Full Text] [Related]
32. Sphingosine 1-phosphate receptor 2 signals through leukemia-associated RhoGEF (LARG), to promote smooth muscle cell differentiation.
Medlin MD; Staus DP; Dubash AD; Taylor JM; Mack CP
Arterioscler Thromb Vasc Biol; 2010 Sep; 30(9):1779-86. PubMed ID: 20702813
[TBL] [Abstract][Full Text] [Related]
33. STAT3 Protein Regulates Vascular Smooth Muscle Cell Phenotypic Switch by Interaction with Myocardin.
Liao XH; Wang N; Zhao DW; Zheng DL; Zheng L; Xing WJ; Ma WJ; Bao LY; Dong J; Zhang TC
J Biol Chem; 2015 Aug; 290(32):19641-52. PubMed ID: 26100622
[TBL] [Abstract][Full Text] [Related]
34. SOX9 and myocardin counteract each other in regulating vascular smooth muscle cell differentiation.
Xu Z; Ji G; Shen J; Wang X; Zhou J; Li L
Biochem Biophys Res Commun; 2012 Jun; 422(2):285-90. PubMed ID: 22580282
[TBL] [Abstract][Full Text] [Related]
35. Myocardin: a component of a molecular switch for smooth muscle differentiation.
Chen J; Kitchen CM; Streb JW; Miano JM
J Mol Cell Cardiol; 2002 Oct; 34(10):1345-56. PubMed ID: 12392995
[TBL] [Abstract][Full Text] [Related]
36. IQGAP1 promotes the phenotypic switch of vascular smooth muscle by myocardin pathway: a potential target for varicose vein.
Huang X; Jin Y; Zhou D; Xu G; Huang J; Shen L
Int J Clin Exp Pathol; 2014; 7(10):6475-85. PubMed ID: 25400725
[TBL] [Abstract][Full Text] [Related]
37. Myocardin enhances Smad3-mediated transforming growth factor-beta1 signaling in a CArG box-independent manner: Smad-binding element is an important cis element for SM22alpha transcription in vivo.
Qiu P; Ritchie RP; Fu Z; Cao D; Cumming J; Miano JM; Wang DZ; Li HJ; Li L
Circ Res; 2005 Nov; 97(10):983-91. PubMed ID: 16224064
[TBL] [Abstract][Full Text] [Related]
38. MYOSLID Is a Novel Serum Response Factor-Dependent Long Noncoding RNA That Amplifies the Vascular Smooth Muscle Differentiation Program.
Zhao J; Zhang W; Lin M; Wu W; Jiang P; Tou E; Xue M; Richards A; Jourd'heuil D; Asif A; Zheng D; Singer HA; Miano JM; Long X
Arterioscler Thromb Vasc Biol; 2016 Oct; 36(10):2088-99. PubMed ID: 27444199
[TBL] [Abstract][Full Text] [Related]
39. PDGF-DD, a novel mediator of smooth muscle cell phenotypic modulation, is upregulated in endothelial cells exposed to atherosclerosis-prone flow patterns.
Thomas JA; Deaton RA; Hastings NE; Shang Y; Moehle CW; Eriksson U; Topouzis S; Wamhoff BR; Blackman BR; Owens GK
Am J Physiol Heart Circ Physiol; 2009 Feb; 296(2):H442-52. PubMed ID: 19028801
[TBL] [Abstract][Full Text] [Related]
40. Drug-eluting stent specifically designed to target vascular smooth muscle cell phenotypic modulation attenuated restenosis through the YAP pathway.
Huang C; Zhang W; Zhu Y
Am J Physiol Heart Circ Physiol; 2019 Sep; 317(3):H541-H551. PubMed ID: 31298560
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
